From earlier today - Rkmatters:
"Do you know how much hospitals are paid to be part of the clinical trial? In one of Pearlson's comments back to me yesterday, he said NYU has stopped recruiting because they aren't being paid much (my nephew was treated there). Meanwhile, they recruited for years, and so did Overlook. Both remain active (meaning they have patients still receiving the vaccine) but have stopped enrollment. I believe Anthony's doctor was Dr. Michael Gruber, but he had so many, and I don't want to ask my brother. I know as of December 2013, Overlook still referred to the study. Anyway, what I'm really asking is that "not getting paid much" possibly just code for enrollment being close to done in the US, so they are scaling on sites here, but mostly adding patients overseas before the HE payor kicks in coverage? For a hospital, who frankly isn't doing much as far as DC Vax-L treatment is concerned, to suddenly bow out after years of being in the study and him to be told (by whom I don't know) it's related to payment is odd. Wonder if you had thoughts on this."
No further discussion on this? I find it quite odd too. I believe the vaccine has to be provided at no cost to the clinics and of course imagined training and setup costs for each facility prior to treatment, but does NWBO have to pay other fees on top of all that? Does anyone know if this is per patient, amount, etc? Maybe this is why some of the other sites have also withdrawn. If additional sites withdraw, how much of an impact will this have on the already very slow enrollment?
